- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00918528
Effect of Mitomycin C on Urethral Stricture Recurrence After Internal Urethrotomy
June 10, 2009 updated by: Hillel Yaffe Medical Center
The aim of this study is to evaluate the efficacy of local injected mitomycin C at the time of internal urethrotomy in order to prevent the recurrence of urethral strictures.
Study Overview
Status
Unknown
Conditions
Intervention / Treatment
Study Type
Interventional
Phase
- Phase 2
- Phase 1
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Hadera, Israel, 38100
- Hillel Yaffe Medical Center
-
Contact:
- Michael Mullerad, MD
- Phone Number: 972-4-630-4440
-
Contact:
- Nachum Erlich, MD
- Phone Number: 972-4-630-4440
- Email: erlichn@hy.health.gov.il
-
Principal Investigator:
- Michael Mullerad, MD
-
Principal Investigator:
- Nachum Erlich, MD
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 85 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
Male
Description
Inclusion Criteria:
- Male urethral stricture suitable for internal urethrotomy
- Stricture length less than 10 mm
Exclusion Criteria:
- Stricture length over 10 mm
- Benign prostate enlargement
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: 1. Internal urethrotomy
|
|
Experimental: 2. Internal urethrotomy + mitomycin C
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Urethral stricture recurrence
Time Frame: One year
|
One year
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
June 1, 2009
Study Registration Dates
First Submitted
June 9, 2009
First Submitted That Met QC Criteria
June 10, 2009
First Posted (Estimate)
June 11, 2009
Study Record Updates
Last Update Posted (Estimate)
June 11, 2009
Last Update Submitted That Met QC Criteria
June 10, 2009
Last Verified
June 1, 2009
More Information
Terms related to this study
Additional Relevant MeSH Terms
- Urologic Diseases
- Pathological Conditions, Anatomical
- Urethral Diseases
- Urethral Obstruction
- Constriction, Pathologic
- Urethral Stricture
- Molecular Mechanisms of Pharmacological Action
- Nucleic Acid Synthesis Inhibitors
- Enzyme Inhibitors
- Antineoplastic Agents
- Alkylating Agents
- Antibiotics, Antineoplastic
- Mitomycins
- Mitomycin
Other Study ID Numbers
- 0020-09-HYMC
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Urethral Stricture
-
Urotronic Inc.WithdrawnLower Urinary Tract Symptoms | Urethral Stricture | Urethral Stricture, Anterior | Anterior Urethral Stricture
-
University of California, San FranciscoRecruitingUrethral Stricture, MaleUnited States
-
University Hospital, GhentWithdrawnUrethral Stricture DiseaseBelgium
-
University Hospital, GhentCompletedAnterior Urethral Stricture, MaleBelgium
-
Lepu Medical Technology (Beijing) Co., Ltd.Recruiting
-
University Hospital Virgen de las NievesInstituto de Investigación Biosanitaria de Granada (ibs.Granada)RecruitingFibrosis | Hormone Deficiency | Urethral Stricture, MaleSpain
-
Ain Shams UniversityCompletedUrethral Stricture, MaleEgypt
-
Regenosca SARecruiting
-
Ain Shams UniversityCompletedUrethral StrictureEgypt
Clinical Trials on Internal urethrotomy
-
Sheba Medical CenterUnknownUrethral StricturesIsrael
-
Ain Shams UniversityCompletedUrethral Stricture, MaleEgypt
-
Lepu Medical Technology (Beijing) Co., Ltd.Recruiting
-
Ain Shams UniversityCompletedUrethral Stricture, MaleEgypt
-
Urotronic Inc.ClinLogix. LLCActive, not recruitingUrethral StrictureUnited States, Canada
-
Hannes KortekangasRecruitingUrethral Stricture | Fat GraftFinland
-
Jiangxi Qingfeng Pharmaceutical Co. Ltd.Unknown
-
University Hospital, GrenobleRecruiting
-
Assistance Publique Hopitaux De MarseilleRecruiting
-
HaEmek Medical Center, IsraelCompleted